Opinion
2021-1078 2021-1084 2021-1086 2021-1087 2021-1088 2021-1090 2021-1091 2021-1092 2021-1093 2021-1094 2021-1095 2021-1096 2021-1097 2021-1098 2021-1441
10-31-2022
BIOGEN INTERNATIONAL GMBH, BIOGEN MA INC., Plaintiffs-Appellants v. AMNEAL PHARMACEUTICALS LLC, ALKEM LABORATORIES LTD., HETERO USA INC., CIPLA LIMITED, CIPLA USA INC., HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-III, LUPIN ATLANTIS HOLDINGS SA, MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS INC., PHARMATHEN S.A., PRINSTON PHARMACEUTICAL INC., S&B PHARMA, INC., SANDOZ INC., SHILPA MEDICARE LIMITED, SUN PHARMACEUTICAL INDUSTRIES, INC., SUN PHARMA GLOBAL FZE, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., TWI PHARMACEUTICALS INC., TWI PHARMACEUTICALS USA, INC., Defendants-Appellees ACCORD HEALTHCARE INC., GRAVITI PHARMACEUTICALS INC., GRAVITI PHARMACEUTICALS PVT. LTD., IMPAX LABORATORIES LLC, MACLEODS PHARMA USA, INC., MACLEODS PHARMACEUTICALS LTD., SLAYBACK PHARMA LLC, SLAYBACK PHARMA INDIA LLP, TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LTD., WINDLAS HEALTHCARE PVT. LTD., Defendants
This Order is Nonprecedential.
Appeals from the United States District Court for the District of Delaware in Nos. 1:17-cv-00823-MN, 1:17-cv-00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN, 1:17-cv-00846-MN, 1:17-cv-00847-MN, 1:17-cv-00850-MN, 1:17-cv-00851-MN, 1:17-cv-00853-MN, 1:17-cv-00855-MN, 1:17-cv-00856-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv-00954-MN, and 1:20-cv-01159-MN, Judge Maryellen Noreika.
ON MOTION
ORDER
Upon consideration of appellants' unopposed motion to voluntarily dismiss the above-captioned consolidated appeals pursuant to Federal Rule of Appellate Procedure 42(b) with each party to bear its own costs upon dismissal, IT IS ORDERED THAT:
(1) The motion is granted. The above-captioned appeals are dismissed.
(2) Any other pending motion is denied as moot.
(3) Each side shall bear its own costs.